Rare lymphoma patient’s experience at OHSU inspires gift
David Brockman came to OHSU for CAR T-cell treatment to treat a rare type of lymphoma. His positive experience inspired him to give on Give Day 2023.
Impact Area: Cancer
The OHSU Knight Cancer Institute is a world leader in targeted therapy and early detection. Help us create a world free from the burden of cancer.
Hero-Up for Children’s Cancer Race in its 11th year connecting heroes to childhood cancer research
Now in its 11th year, Hero-Up combines Keith’s love of superheroes and Burnett’s passion for running into a 5k and kids’ fun run that brings hundreds of runners and superheroes alike to the starting line.
Knight Cancer Institute Introductions: Meet the team
Meet three members of the team at the Knight Cancer Institute: Elizabeth Berry, M.D., Olabisi Sanusi, M.D., and Reid Thompson, M.D., Ph.D.
Cancer patient, PA student sees two sides of OHSU
For Alex Edgell, his experience as both a PA student and cancer patient creates a complete picture of OHSU.
Ending the burden of cancer: Episode 2
Follow Derrik Zebroski, the mobile outreach coordinator at the OHSU Knight Cancer Institute, as he drives to work with rural communities across Oregon.
Experience at OHSU reconciles cancer patient’s longstanding doubts about medicine
Jack Hennessy had always been skeptical about modern medicine — until he was diagnosed with prostate cancer and began treatment at OHSU.
The promise of early detection: how one blood draw found cancer
Joyce participated in a research study, never dreaming that a single blood draw would find cancer.
Donor support sparks crucial advances in pancreatic research
The Brenden-Colson Center for Pancreatic Care has leveraged exceptional philanthropic support to achieve great advances in the detection and treatment of pancreatic cancer and disease.
Here for you
This holiday season, we celebrate you and the spirit of giving that makes a difference in people’s lives. We’ve gathered a few of the heartwarming, inspiring stories this past year made possible by people like you.
Four questions with Shivaani Kummar, MD, FACP
Dr. Kummar’s work is dedicated to early phase clinical trials — discovering new therapies for cancer and giving more people access to safe, experimental cancer treatments.
